Data / Drug companies / Propafenone hydrochloride
Propafenone hydrochloride: 15 companies and 50 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Propafenone hydrochloride is listed in the FDA National Drug Code Directory by 15 companies, with 50 products in commercial distribution. 50 of the products (100.0%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule, extended release; tablet, coated; tablet, film coated, and the newest product started marketing on October 21, 2025.
The request: Get every company that lists propafenone hydrochloride in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 15
- Products
- 50
- Generic (ANDA) products
- 50 (100.0%)
- Application numbers
- 8
- Routes
- Oral
- openFDA record search
- api.fda.gov
Companies that list propafenone hydrochloride
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Aurobindo Pharma Limited | 6 | tablet, film coated; capsule, extended release | Generic drugs (ANDA) | February 21, 2023 |
| Bryant Ranch Prepack | 6 | tablet, film coated; tablet, coated | Generic drugs (ANDA) | October 25, 2019 |
| Strides Pharma Science Limited | 6 | tablet, film coated | Generic drugs (ANDA) | May 5, 2025 |
| Bryant Ranch Prepack | 4 | tablet, coated | Generic drugs (ANDA) | March 31, 2015 |
| Ani Pharmaceuticals, Inc. | 3 | tablet, coated | Generic drugs (ANDA) | March 31, 2015 |
| Glenmark Pharmaceuticals Inc., USA | 3 | capsule, extended release | Generic drugs (ANDA) | September 8, 2017 |
| Golden State Medical Supply, Inc. | 3 | tablet, coated | Generic drugs (ANDA) | April 23, 2004 |
| NorthStar Rx LLC | 3 | capsule, extended release | Generic drugs (ANDA) | March 31, 2017 |
| Rising Pharma Holdings, Inc. | 3 | capsule, extended release | Generic drugs (ANDA) | December 16, 2020 |
| Upsher-Smith Laboratories, LLC | 3 | capsule, extended release | Generic drugs (ANDA) | June 25, 2020 |
| Zydus Lifesciences Limited | 3 | capsule, extended release | Generic drugs (ANDA) | February 2, 2022 |
| Zydus Pharmaceuticals USA Inc. | 3 | capsule, extended release | Generic drugs (ANDA) | February 2, 2022 |
| American Health Packaging | 2 | tablet, film coated | Generic drugs (ANDA) | October 21, 2025 |
| A-S Medication Solutions | 1 | tablet, coated | Generic drugs (ANDA) | March 31, 2015 |
| Bryant Ranch Prepack | 1 | tablet, coated | Generic drugs (ANDA) | March 31, 2015 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Capsule, extended release | 21 | 42% |
| Tablet, coated | 15 | 30% |
| Tablet, film coated | 14 | 28% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 50 | 100% |
Pharmacologic classes
| Class | Products |
|---|---|
| Antiarrhythmic | 50 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.